|Day Low/High||1,295.65 / 1,317.00|
|52 Wk Low/High||970.11 / 1,323.74|
If you were reading TheStreet that day five years ago, here are three other stories you would have seen.
Anadarko has almost 40% upside. Abbott has 20% upside.
Many tech names were shaken Tuesday.
Alphabet's deal with Avis could lead to consumer acceptance of autonomous cars.
Cramer's take on these hot FAANGs.
AAPL is too pricey here, while FB and GOOGL would look better on a dip.
Warren Buffett is famous for being wary of investing in tech stocks.
U.K. Prime Minister Theresa May says technology companies have to do more to combat hate speech.
Tech momentum names don't put on much of a show.
MIT survey finds only 13% would feel comfortable in an automated vehicle.
Don't expect any meaningful change in the Russell 2000 ETF.
The nutritional supplements company on Monday unveiled a deal to sell to private equity firm HGGC in a transaction valued at about $446M, including debt to be refinanced.
Davids that follow Amazon's example may ultimately beat Goliath to the punch.
Inovio Pharmaceuticals, Neurocrine Biosciences and Alnylam Pharmaceuticals were among the biotech movers in premarket trading on Wednesday.
The U.S. auto supplier will integrate a self-driving system for BMW by 2021 that also will be for sale to rival automakers.
The board was prompted to act by Jana Partners, which has a 9% stake in the grocer.
Forget FANG--these three large-cap stocks look ready to lead the tech sector higher as we head toward the summer months.
Amazon's latest device launches as the Echo sees big growth with Millennials.
The semiconductor giant is redoubling efforts to capitalize on opportunities in autonomous and driverless vehicles.
With two new initiatives this week alone, Asian governments are leading the drive for autonomous cars.
Lack of action doesn't mean traders aren't occupied.
President Trump has talked about a tax holiday, letting companies with cash overseas repatriate their earnings at a low tax rate. Companies like Alphabet, Microsoft and others could benefit.
Small caps are down 0.12% despite the strength in the Nasdaq ETF.
If the uptrend line holds, perhaps shorter timeframe buyers have a shot at testing the mid-$50s.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.